Osaic Holdings’s AstraZeneca AZN Stock Holding History

Osaic Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.6K	Hold	2	–	–	﹤0.01%	6873
2026 Q1	$6.5K	Buy	2 +1	+100%	+$193	﹤0.01%	6539
2025 Q4	$5.51K	Buy	+1	New	+$175	﹤0.01%	6659

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Osaic Holdings's AZN Position: Q2 2026 in Review

Osaic Holdings increased its AstraZeneca (AZN) stake by 73% in Q2 2026, buying an estimated $9.5M and bringing the position to 119,910 shares worth $22.6M. The position accounts for 0.03% of the portfolio, ranked #622.

Osaic Holdings first reported a position in AZN in Q1 2020 and has held it in 26 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Osaic Holdings held 119,910 shares of AstraZeneca worth $22.6M as of Q2 2026.
Osaic Holdings bought 50,493 AstraZeneca shares in Q2 2026, an estimated $9.5M.
AstraZeneca made up 0.03% of Osaic Holdings's portfolio in Q2 2026, its #622 holding.
Osaic Holdings first reported a position in AstraZeneca in Q1 2020 and has held it in 26 quarters since.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.